BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 09/04/2014

FDA Withdraws Approval of Bupropion Hydrochloride Extended-Release Tablets

The Food and Drug Administration has withdrawn approval of Watson Laboratories' Bupropion Hydrochloride Extended-Release Tablets, 300 milligrams, following a voluntary request from the company.

Source: Federal Register — Food and Drug AdministrationOpen original release →